en
Scientific article
Open access
English

Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants

Published inFrontiers in microbiology, vol. 13, 998287
Publication date2022-10-12
First online date2022-10-12
Keywords
  • COVID-19
  • Direct-acting antivirals
  • Immunocompromised
  • Monoclonal antibodies
  • Omicron
  • Resistance
  • Variant emergence
  • Variants
Research group
Citation (ISO format)
HENTZIEN, Maxime et al. Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants. In: Frontiers in microbiology, 2022, vol. 13, p. 998287. doi: 10.3389/fmicb.2022.998287
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1664-302X
36views
5downloads

Technical informations

Creation02/07/2023 8:48:24 AM
First validation11/17/2023 6:49:57 PM
Update time11/17/2023 6:49:57 PM
Status update11/17/2023 6:49:57 PM
Last indexation05/06/2024 5:24:27 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack